Skip to search formSkip to main contentSkip to account menu

erythrosol

Known as: RAS2 solution 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Background: Treatment of RBC with S-303 (acridine derivative) inactivates pathogens and leukocytes. The original process for S… 
2006
2006
BACKGROUND:  Development of a robust pathogen reduction system for red cells (RBCs) utilizing photosensitive dyes has been… 
2002
2002
BACKGROUND : Limited photoinactivation kinetics, use of low‐volume 30 percent Hct RBCs, and hemolysis have restricted the…